Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1968 1
1969 1
1982 1
1983 2
1985 1
1986 1
1988 1
1989 1
1990 1
1991 2
1993 1
1994 1
1995 1
1996 3
1997 2
1998 3
1999 9
2000 5
2001 5
2002 16
2003 8
2004 17
2005 23
2006 23
2007 18
2008 21
2009 22
2010 27
2011 20
2012 19
2013 20
2014 16
2015 10
2016 3
2017 4
2018 3
2019 5
2020 5
2021 5
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 12697881

297 results

Results by year

Filters applied: . Clear all
Page 1
Pemetrexed: a multitargeted antifolate.
Rollins KD, Lindley C. Rollins KD, et al. Clin Ther. 2005 Sep;27(9):1343-82. doi: 10.1016/j.clinthera.2005.09.010. Clin Ther. 2005. PMID: 16291410 Review.
Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma.
Ceresoli GL, Zucali PA, Favaretto AG, Grossi F, Bidoli P, Del Conte G, Ceribelli A, Bearz A, Morenghi E, Cavina R, Marangolo M, Parra HJ, Santoro A. Ceresoli GL, et al. J Clin Oncol. 2006 Mar 20;24(9):1443-8. doi: 10.1200/JCO.2005.04.3190. J Clin Oncol. 2006. PMID: 16549838 Clinical Trial.
Pemetrexed in malignant pleural mesothelioma.
Hazarika M, White RM Jr, Booth BP, Wang YC, Ham DY, Liang CY, Rahman A, Gobburu JV, Li N, Sridhara R, Morse DE, Lostritto R, Garvey P, Johnson JR, Pazdur R. Hazarika M, et al. Clin Cancer Res. 2005 Feb 1;11(3):982-92. Clin Cancer Res. 2005. PMID: 15709163
Phase I and pharmacokinetic study of pemetrexed administered every 3 weeks to advanced cancer patients with normal and impaired renal function.
Mita AC, Sweeney CJ, Baker SD, Goetz A, Hammond LA, Patnaik A, Tolcher AW, Villalona-Calero M, Sandler A, Chaudhuri T, Molpus K, Latz JE, Simms L, Chaudhary AK, Johnson RD, Rowinsky EK, Takimoto CH. Mita AC, et al. J Clin Oncol. 2006 Feb 1;24(4):552-62. doi: 10.1200/JCO.2004.00.9720. Epub 2006 Jan 3. J Clin Oncol. 2006. PMID: 16391300 Clinical Trial.
FDA drug approval summaries: pemetrexed (Alimta).
Hazarika M, White RM, Johnson JR, Pazdur R. Hazarika M, et al. Oncologist. 2004;9(5):482-8. doi: 10.1634/theoncologist.9-5-482. Oncologist. 2004. PMID: 15477632 Free article. Review.
297 results